NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects Administration, Oral ✖Remove constraint Subjects: Administration, Oral Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1. Identifying patient harm from direct oral anticoagulants

Author(s):
Valentine, David, author
Gaunt, Michael J., author
Grissinger, Matthew, author
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, June 2018
Subject(s):
Administration, Oral
Anticoagulants -- administration & dosage
Anticoagulants -- adverse effects
Medication Errors -- statistics & numerical data
Adult
Aged
Aged, 80 and over
Antithrombins -- administration & dosage
Antithrombins -- adverse effects
Dabigatran -- administration & dosage
Dabigatran -- adverse effects
Forecasting
Hemorrhage -- chemically induced
Medication Errors -- prevention & control
Medication Errors -- trends
Middle Aged
Patient Safety
Rivaroxaban -- administration & dosage
Rivaroxaban -- adverse effects
Humans
Pennsylvania
United States

2. Oral medications inadvertently given via the intravenous route

Author(s):
Shah-Mohammadi, Ali-Reza, author
Gaunt, Michael J., author
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, [2013]
Subject(s):
Medication Errors -- prevention & control
Medication Errors -- statistics & numerical data
Administration, Oral
Infusions, Intravenous
Injections, Intravenous
Patient safety
Pharmaceutical Preparations -- administration & dosage
Risk Management
Syringes
Humans
Pennsylvania
United States

3. Oral anticoagulants: a review of common errors and risk reduction strategies

Author(s):
Andreica, Ivyruth, author
Grissinger, Matthew, author
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, June 2015
Subject(s):
Anticoagulants -- adverse effects
Anticoagulants -- therapeutic use
Medication Errors -- prevention & control
Medication Therapy Management
Administration, Oral
Anticoagulants -- administration & dosage
Drug Monitoring
Drug Prescriptions -- standards
Inservice Training
International Normalized Ratio
Risk Management
Humans
Pennsylvania
United States

4. Radiology contrast concerns: reports of extravasation and allergic reactions

Author(s):
Gardner, Lea Anne, author
Scott, Kelly, author
Magee, Mary C., author
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, June 2017
Subject(s):
Contrast Media -- adverse effects
Drug Hypersensitivity -- epidemiology
Extravasation of Diagnostic and Therapeutic Materials -- epidemiology
Administration, Oral
Adult
Age Factors
Child
Contrast Media -- administration & dosage
Diagnostic Imaging -- adverse effects
Infant
Infusions, Intravenous
Injections, Intravenous
Iodine Compounds -- adverse effects
Patient safety
Risk Factors
Humans
Pennsylvania
United States

5. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
Subject(s):
Abuse-Deterrent Formulations -- standards
Analgesics, Opioid -- administration & dosage
Drugs, Generic
Investigational New Drug Application
Administration, Oral
Administration, Inhalation
Clinical Trials as Topic
Drug Evaluation, Preclinical
Injections
Research Design
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

6. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, December 2017
Subject(s):
Biological Availability
Drugs, Investigational -- pharmacokinetics
Investigational New Drug Application
Therapeutic Equivalency
Administration, Oral
Biopharmaceutics -- classification
Drugs, Investigational -- administration & dosage
Excipients
Permeability
Prodrugs
Solubility
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

7. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

Author(s):
Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Armstrong, Katrina A., author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
Subject(s):
Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Drug Costs
Financing, Personal -- statistics & numerical data
Medication Adherence -- statistics & numerical data
Administration, Oral
Antineoplastic Agents -- administration & dosage
Health Services Accessibility
Prescription Drugs -- economics
Socioeconomic Factors
Time Factors
Humans
United States

11. Compounding certain ibuprofen oral suspension products under section 503B of the Federal Food, Drug, and Cosmetic Act

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2023
Subject(s):
Administration, Oral
Drug Compounding -- methods
Drug Compounding -- standards
Drug Industry
Government Regulation
Ibuprofen
Legislation, Drug
Suspensions
United States
United States. Food and Drug Administration
United States.

12. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Nikitin, Dmitriy, author
Agboola, Foluso, author
McKenna, Avery, author
Herron-Smith, Serina, author
Pearson, Steven D, author
Campbell, Jonathan D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 21, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Treatment Outcome
Administration, Oral
United States